Next Treatments
Back to Eczema

MK-6194

TypeInjection StagePhase 1 Latest updateJun 5, 2025Phase 1 results posted

What stands out

  • Injection every 2 weeks in trials
Derived from NCT05450198 · This is a summary of public records for informational purposes only. It is not medical advice.

History

Earliest recorded event: Aug 8, 2022. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • Jun 5, 2025Phase 1 results postedMultiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008) ClinicalTrials.gov NCT05450198
  • May 22, 2024Phase 1 trial completedMultiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008) ClinicalTrials.gov NCT05450198
  • Aug 8, 2022Phase 1 trial startedMultiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008) ClinicalTrials.gov NCT05450198

Sources

Trials